US2022347348A1PendingUtilityA1
Customized hybrid bone-implant grafts
Assignee: NEW YORK STEM CELL FOUND INCPriority: Apr 1, 2016Filed: May 10, 2022Published: Nov 3, 2022
Est. expiryApr 1, 2036(~9.7 yrs left)· nominal 20-yr term from priority
A61L 27/06A61L 2430/06A61F 2/2803A61L 27/3608C12N 2506/45A61L 27/3834A61K 35/44C12N 5/0697A61L 27/3691A61K 35/28A61K 35/545A61L 2430/02A61K 35/32A61L 27/3886
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides customized hybrid bone-implant grafts and a method of manufacture thereof.
Claims
exact text as granted — not AI-modified1 - 59 . (canceled)
60 . A hybrid bone-implant graft comprising:
a) an implant material; and b) an engineered bone tissue graft having a scaffold, wherein the graft is composed of cells seeded on the scaffold and cultured to promote attachment of the cells to the implant material.
61 . A kit for generating a hybrid bone-implant graft comprising:
a) one or more populations of tissue forming cells; b) one or more scaffolds; and c) an implant material.
62 . A perfusion bioreactor comprising:
a) one or more graft chambers; b) a culture medium reservoir; and c) a tubing circuit;
wherein each of the one or more graft chambers has a size and geometry corresponding to a tissue graft or segment thereof
63 . A method of preparing a hybrid bone-implant graft, the method comprising culturing one or more populations of cells on a scaffold to form a tissue graft, wherein the tissue graft is cultured with an implant material to promote attachment of the cells to the implant material.
64 . The method of claim 63 , wherein the tissue graft is a bone graft.
65 . The method of claim 63 , wherein the tissue graft is a cartilage graft.
66 . The method of claim 63 , wherein the tissue graft is vascularized.
67 . The method of claim 63 , wherein the tissue graft has a thickness of about one centimeter or less.
68 . The method of claim 63 , wherein the tissue graft has a thickness of from about 0.3 millimeters to about 10 millimeters.
69 . The method of claim 63 , wherein the scaffold is generated using computer assisted manufacturing, three-dimensional printing, casting, milling, laser cutting, rapid prototyping, or any combination thereof.
70 . The method of claim 63 , wherein the cells are derived from induced pluripotent stem cells.
71 . The method of claim 63 , wherein the cells comprise bone-forming cells and/or cells capable of differentiating into bone-forming cells.
72 . The method of claim 63 , wherein the cells comprise blood vessel-forming cells and/or cells capable of differentiating into blood vessel-forming cells.
73 . The method of claim 63 , wherein the cells comprise endothelial progenitor cells.
74 . A method of forming the hybrid bone-implant graft of claim 63 , the method comprising attaching the tissue graft to the implant material.
75 . The method of claim 74 , wherein the tissue graft is seeded with cells before attachment to the implant material.
76 . The method of claim 74 , wherein the tissue graft is seeded with cells after attachment to the implant material.
77 . The method of claim 74 , wherein the implant material and tissue graft are threadably attached.
78 . The method of claim 74 , wherein the implant material and tissue graft are manually attached or attached via a mechanized tool.
79 . The method of claim 74 , wherein the implant material and tissue graft are attached by boring a hole into the tissue graft and inserting the implant material into the hole.Join the waitlist — get patent alerts
Track US2022347348A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.